Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease

World Journal of Gastroenterology

Volumn 12, Issue 30, 2006, Pages 4773-4783

  Cox, I Jane ^a   Sharif, Amar ^a   Cobbold, Jeremy F L ^a   Thomas, Howard C ^a   Taylor Robinson, Simon D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Hepatobiliary disease; Liver; Magnetic resonance spectroscopy; Membrane metabolism

Indexed keywords

BIOLOGICAL MARKER; IRON;

BIOCHEMISTRY; BODY FLUID; CELL METABOLISM; CHRONIC LIVER DISEASE; DISEASE SEVERITY; EDITORIAL; FATTY LIVER; GENE THERAPY; HEPATOBILIARY DISEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IRON OVERLOAD; LIVER CANCER; LIVER FAILURE; LIVER TRANSPLANTATION; MAGNETIC FIELD; METHODOLOGY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; SCREENING;

EID: 33748299586     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i30.4773     Document Type: Editorial

References (82)

1. Bloch F, Hansen WW, Packard ME. Nuclear induction. Physics Review 1946; 69: 127
2. Jacobson B, Anderson WA, Arnold JT. A proton magnetic resonance study of the hydration of deoxyribonucleic acid. Nature 1954; 17: 772-773
3. Lindon JC, Holmes E, Nicholson JK. Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagn 2004; 4: 189-199
4. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 2005; 18: 143-162
5. Cox IJ, Menon DK, Sargentoni J, Bryant DJ, Collins AG, Coutts GA, Iles RA, Bell JD, Benjamin IS, Gilbey S. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. J Hepatol 1992; 14: 265-275
6. Cox IJ. Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog Biophys Mol Biol 1996; 65: 45-81
7. Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 1995; 21: 417-427
8. Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003; 37: 788-794
9. Schilling A, Gewiese B, Berger G, Boese-Landgraf J, Fobbe F, Stiller D, Gallkowski U, Wolf KJ. Liver tumors: follow-up with P-31 MR spectroscopy after local chemotherapy and chemoembolization. Radiology 1992; 182: 887-890
10. Tanoli T, Yue P, Yablonskiy D, Schonfeld G. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, infra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res 2004; 45: 941-947
11. Thomas EL, Hamilton G, Patel N, O'Dwyer R, Dore CJ, Goldin RD, Bell JD, Taylor-Robinson SD. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005; 54: 122-127
12. Iles RA, Stevens AN, Griffiths JR, Morris PG. Phosphorylation status of liver by 31P-n.m.r. spectroscopy, and its implications for metabolic control. A comparison of 31P-n.m.r. spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi. Biochem J 1985; 229: 141-151
13. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992; 5: 226-233
14. Deprez S, Sweatman BC, Connor SC, Haselden JN, Waterfield CJ. Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profiles. J Pharm Biomed Anal 2002; 30: 1297-1310
15. Bourne R, Dzendrowskyj T, Mountford C. Leakage of metabolites from tissue biopsies can result in large errors in quantitation by MRS. NMR Biomed 2003; 16: 96-101
16. Tang H, Wang Y, Nicholson JK, Lindon JC. Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem 2004; 325: 260-272
17. Chen JH, Sambol EB, Kennealey PT, O'Connor RB, DeCarolis PL, Cory DG, Singer S. Water suppression without signal loss in HR-MAS 1H NMR of cells and tissues. J Magn Reson 2004; 171: 143-150
18. Cheng LL, Lean CL, Bogdanova A, Wright SC Jr, Ackerman JL, Brady TJ, Garrido L. Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn Reson Med 1996; 36: 653-658
19. Dave U, Taylor-Robinson SD, Walker MM, Mahon M, Puri BK, Thursz MR, DeSouza NM, Cox IJ. In vitro 1H-magnetic resonance spectroscopy of Barrett's esophageal mucosa using magic angle spinning techniques. Eur J Gastroenterol Hepatol 2004; 16: 1199-1205
20. Hoult DI, Busby SJ, Gadian DG, Radda GK, Richards RE, Seeley PJ. Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature 1974; 252: 285-287
21. McLaughlin AC, Takeda H, Chance B. Rapid ATP assays in perfused mouse liver by 31P NMR. Proc Natl Acad Sci USA 1979; 76: 5445-5449
22. Salhany JM, Stohs SJ, Reinke LA, Pieper GM, Hassing JM. 31P nuclear magnetic resonance of metabolic changes associated with cyanide intoxication in the perfused rat liver. Biochem Biophys Res Commun 1979; 86: 1077-1083
23. Thoma SJ, Uqurbil K. Effects of adenine on liver nucleotide after fructose loading by 31p-NMR. Am Physiol 1989; 256: G949-956
24. Bell JD, Cox IJ, Sargentoni J, Peden CJ, Menon DK, Foster CS, Watanapa P, Iles RA, Urenjak J. A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta 1993; 1225: 71-77
25. Cox IJ, Bell JD, Peden CJ, Iles RA, Foster CS, Watanapa P, Williamson RC. In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed 1992; 5: 114-120
26. Soper R, Himmelreich U, Painter D, Somorjai RL, Lean CL, Dolenko B, Mountford CE, Russell P. Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Pathology 2002; 34: 417-422
27. Taylor-Robinson SD, Sargentoni J, Bell JD, Saeed N, Changani KK, Davidson BR, Rolles K, Burroughs AK, Hodgson HJ, Foster CS, Cox IJ. In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 1997; 17: 198-209
28. Cho SG, Kim MY, Kim HJ, Kim YS, Choi W, Shin SH, Hong KC, Kim YB, Lee JH, Suh CH. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 2001; 221: 740-746
29. Lim AK, Hamilton G, Patel N, Bell JD, Taylor-Robinson SD. H MR spectroscopy in the evaluation of the severity of chronic liver disease. Radiology 2003; 226: 288-289
30. Martinez-Granados B, Monleon D, Martinez-Bisbal MC, Rodrigo JM, del Olmo J, Lluch P, Ferrandez A, Marti-Bonmati L, Celda B. Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H NMR spectroscopy. NMR Biomed 2006; 19: 90-100
31. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, Croce LS, Grigolato P, Paoletti S, de Bernard B. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5: 281-285
32. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-468
33. Duarte IF, Stanley EG, Holmes E, Lindon JC, Gil AM, Tang H, Ferdinand R, McKee CG, Nicholson JK, Vilca-Melendez H, Heaton N, Murphy GM. Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem 2005; 77: 5570-5578
34. Changani KK, Fuller BJ, Bell JD, Bryant DJ, Moore DP, Taylor-Robinson SD, Davidson BR. Hepatic nucleotide triphosphate regeneration after hypothermic reperfusion in the pig model: an in vitro P-NMR study. Transplantation 1996; 62: 787-793
35. Changani KK, Fuller BJ, Bryant DJ, Bell JD, Ala-Korpela M, Taylor-Robinson SD, Moore DP, Davidson BR. Non-invasive assessment of ATP regeneration potential of the preserved donor liver. A 31P MRS study in pig liver. J Hepatol 1997; 26: 336-342
36. Davidson BR, Barnard ML, Changani KK, Taylor-Robinson SD. Liver transplantation: current and potential applications of magnetic resonance spectroscopy. Liver Transpl Surg 1997; 3: 481-493
37. Taylor-Robinson SD, Sargentoni J, Bell JD, Thomas EL, Marcus CD, Changani KK, Saeed N, Hodgson HJ, Davidson BR, Burroughs AK, Rolles K, Foster CS, Cox IJ. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut 1998; 42: 735-743
38. Jalan R, Sargentoni J, Coutts GA, Bell JD, Rolles K, Burroughs AK, Taylor Robinson SD. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. Gut 1996; 39: 141-146
39. Mullenbach R, Bennett A, Tetlow N, Patel N, Hamilton G, Cheng F, Chambers J, Howard R, Taylor-Robinson SD, Williamson C. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 2005; 54: 829-834
40. Stark DD, Moseley ME, Bacon BR, Moss AA, Goldberg HI, Bass NM, James TL. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985; 154: 137-142
41. Stark DD, Moss AA, Goldberg HI. Nuclear magnetic resonance of the liver, spleen, and pancreas. Cardiovasc Intervent Radiol 1986; 8: 329-341
42. Ghugre NR, Coates TD, Nelson MD, Wood JC. Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens. Magn Reson Med 2005; 54: 1185-1193
43. Wang ZJ, Haselgrove JC, Martin MB, Hubbard AM, Li S, Loomes K, Moore JR, Zhao H, Cohen AR. Evaluation of iron overload by single voxel MRS measurement of liver T2. J Magn Reson Imaging 2002; 15: 395-400
44. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-362
45. Bell JD, Taylor-Robinson SD. Assessing gene expression in vivo: magnetic resonance imaging and spectroscopy. Gene Ther 2000; 7: 1259-12264
46. Bhakoo KK, Bell JD, Cox IJ, Taylor-Robinson SD. The application of magnetic resonance imaging and spectroscopy to gene therapy. Methods Enzymol 2004; 386: 303-313
47. Walter G, Barton ER, Sweeney HL. Noninvasive measurement of gene expression in skeletal muscle. Proc Natl Acad Sci USA 2000; 97: 5151-5155
48. Li Z, Qiao H, Lebherz C, Choi SR, Zhou X, Gao G, Kung HF, Rader DJ, Wilson JM, Glickson JD, Zhou R. Creatine kinase, a magnetic resonance-detectable marker gene for quantification of liver-directed gene transfer. Hum Gene Ther 2005; 16: 1429-1438
49. Schiff ER, Sorrell MF, Maddrey WC. Schiff's Diseases of the Liver, 9th edn, 2002: 141
50. Wolkoff AW, Cohen DE. Bile acid regulation of hepatic physiology: I. Hepatocyte transport of bile acids. Am J Physiol Gastrointest Liver Physiol 2003; 284: G175-179
51. van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 1996; 87: 507-517
52. Komichi D, Tazuma S, Nishioka T, Hyogo H, Une M, Chayama K. Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes. Dig Dis Sci 2003; 48: 2315-2322
53. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P, Thomas HC. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001; 48: 816-820
54. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 37: 806-813
55. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-1314
56. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004; 99: 1675-1681
57. Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ, Argani P, Goggins MG, Maitra A, Pandey A. A proteomic analysis of human bile. Mol Cell Proteomics 2004; 3: 715-728
58. Small DM, Penkett SA, Chapman D. Studies on simple and mixed bile salt micelles by nuclear magnetic resonance spectroscopy. Biochim Biophys Acta 1969; 176: 178-189
59. Ishikawa H, Nakashima T, Inaba K, Mitsuyoshi H, Nakajima Y, Sakamoto Y, Okanoue T, Kashima K, Seo Y. Proton magnetic resonance assay of total and taurine-conjugated bile acids in bile. J Lipid Res 1999; 40: 1920-1904
60. Ijare OB, Somashekar BS, Gowda GA, Sharma A, Kapoor VK, Khetrapal CL. Quantification of glycine and taurine conjugated bile acids in human bile using 1H NMR spectroscopy. Magn Reson Med 2005; 53: 1441-1446
61. Ellul JP, Murphy GM, Parkes HG, Slapa RZ, Dowling RH. Nuclear magnetic resonance spectroscopy to determine the micellar cholesterol in human bile. FEBS Lett 1992; 300: 30-32
62. Groen AK, Goldhoorn BG, Egbers PH, Chamuleau RA, Tytgat GN, Bovee WM. Use of 1H-NMR to determine the distribution of lecithin between the micellar and vesicular phases in model bile. J Lipid Res 1990; 31: 1315-1321
63. Pearce JM, Komoroski RA. Resolution of phospholipid molecular species by 31P NMR. Magn Reson Med 1993; 29: 724-731
64. Khristianovich DS, Reshetniak VI, Loginov AS, Iushmanov VE, Tumanian MA. 31P-NMR spectroscopy of the human liver and bile. Biull Eksp Biol Med 1988; 106: 678-681
65. Danchenko E, Petermann H, Chirkin A, Dargel R. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes. Exp Toxicol Pathol 2001; 53: 227-233
66. Sequeira SS, Parkes HG, Ellul JP, Murphy GM. One dimensional high resolution 1H NMR spectroscopy of human bile: lipid-derived resonance shifts. Biochem Soc Trans 1994; 22: 114S
67. Hakk H, Larsen G, Feil V. Tissue distribution, excretion, and metabolism of 1,2,7,8-tetrachlorodibenzo-p-dioxin in the rat. Chemosphere 2001; 42: 975-983
68. Khan SA, Cox IJ, Thillainayagam AV, Bansi DS, Thomas HC, Taylor-Robinson SD. Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur J Gastroenterol Hepatol 2005; 17: 733-738
69. Melendez HV, Ahmadi D, Parkes HG, Rela M, Murphy G, Heaton N. Proton nuclear magnetic resonance analysis of hepatic bile from donors and recipients in human liver transplantation. Transplantation 2001; 72: 855-860
70. Khristianovich DS, Reshetniak VI, Loginov AS, Iushmanov VE, Tumanian MA. 31P-NMR spectroscopy of the human liver and bile. Biull Eksp Biol Med 1988; 106: 678-681
71. Jungst D, Lang T, Huber P, Lange V, Paumgartner G. Effect of phospholipids and bile acids on cholesterol nucleation time and vesicular/micellar cholesterol in gallbladder bile of patients with cholesterol stones. J Lipid Res 1993; 34: 1457-1464
72. Cantafora A, Angelico M, Di Biase A, Pieche U, Bracci F, Attili AF, Capocaccia L. Structure of biliary phosphatidylcholine in cholesterol gallstone patients. Lipids 1981; 16: 589-592
73. Nervi F, Covarrubias C, Bravo P, Velasco N, Ulloa N, Cruz F, Fava M, Severin C, Del Pozo R, Antezana C. Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area. Gastroenterology 1989; 96: 825-830
74. Nishijima T, Nishina M, Fujiwara K. Measurement of lactate levels in serum and bile using proton nuclear magnetic resonance in patients with hepatobiliary diseases: its utility in detection of malignancies. Jpn J Clin Oncol 1997; 27: 13-17
75. Meyerhoff DJ, Karczmar GS, Valone F, Venook A, Matson GB, Weiner MW. Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy. Invest Radiol 1992; 27: 456-464
76. Lim AK, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, Foster GR, Thomas HC, Cosgrove DO, Blomley MJ. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005; 54: 128-133
77. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, Pirisi M. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-845
78. Zakian KL, Koutcher JA, Malhotra S, Thaler H, Jarnagin W, Schwartz L, Fong Y. Liver regeneration in humans is characterized by significant changes in cellular phosphorus metabolism: assessment using proton-decoupled 31P-magnetic resonance spectroscopic imaging. Magn Reson Med 2005; 54: 264-271
79. Dobbins RL, Malloy CR. Measuring in-vivo metabolism using nuclear magnetic resonance. Curr Opin Clin Nutr Metab Care 2003; 6: 501-509
80. Fluck CE, Slotboom J, Nuoffer JM, Kreis R, Boesch C, Mullis PE. Normal hepatic glycogen storage after fasting and feeding in children and adolescents with type 1 diabetes. Pediatr Diabetes 2003; 4: 70-76
81. Roden M, Petersen KF, Shulman GI. Nuclear magnetic resonance studies of hepatic glucose metabolism in humans. Recent Prog Horm Res 2001; 56: 219-237
82. Komichi D, Tazuma S, Nishioka T, Hyogo H, Chayama K. A nuclear receptor ligand down-regulates cytosolic phospholipase A2 expression to reduce bile acid-induced cyclooxygenase 2 activity in cholangiocytes: implications of anticarcinogenic action of farnesoid X receptor agonists. Dig Dis Sci 2005; 50: 514-524